ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 18.39 trillion as of May 9, 2025. Its market cap has increased by 115.53% in one year.

Market Cap

18.39T

Enterprise Value

18.30T

Revenue

102.85B

Ranking

n/a

PE Ratio

296.65

Stock Price

345,000.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 18.39T, an increase of 15,228.01%. That is a compound annual growth rate of 62.15%.

Market Cap History

Date	Market Cap	% Change
May 8, 2025	18.79T	13.89%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.09T
Celltrion	34.18T
Yuhan	8,214.16B
SK Biopharmaceuticals	7,753.01B
HLB Co., Ltd.	7,712.59B
PharmaResearch	3,948.07B
Peptron	3,846.39B
LigaChem Biosciences	3,657.23B

Market Cap Rankings